Vaccine | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Pharmaceutical The Market Buzz Your Environment

Johnson & Johnson to Deliver U.S 100 Million Doses of Coronavirus Vaccine

Rebecca Urena08/05/2020

679

Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it has reached an agreement with the U.S. to provide 100 million doses of it COVID-19 vaccine for a sum of...

Investing News Market News Technology

BioNTech SE and Pfizer Inc. announced initial data from their ongoing German Phase ½ COVID-19 Vaccine Study

Danny Abramov07/20/2020

4165

BioNTech SE (NASDAQ: BNTX) and Pfizer Inc. (NYSE: PFE) announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global...

Healthcare Investing News Market News Technology The Market Buzz

J&J Profit Plummets 35%

Rebecca Urena07/16/202007/16/2020

4783

Johnson & Johnson (NYSE: JNJ) second quarter profit plummets 35% amid the coronavirus pandemic. The lack of demand for beauty products and medical equipment has taken a toll on...

Biotechnology Healthcare Investing News Market News

Biotech Sector Pursues a Vaccine as COVID-19 Cases Continue to Rise

Danny Abramov06/26/2020

11295

The number of new COVID-19 cases per day in the United States continues to rise. While significantly expanded testing probably accounts for the increase in numbers, some experts claim...

Investing News Market News

Catalent and Moderna Report Collaboration to Manufacture Moderna’s Coronavirus Vaccine Candidate

Bryan Shin06/25/2020

5224

Moderna, Inc. (NASDAQ: MRNA) and Catalent, Inc. (NYSE: CTLT) have announced a collaboration to large scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics...

Biotechnology Investing News Market News Technology

Germany to Acquire stake in CureVac to Search for Coronavirus Vaccine

Nikita Medvedev06/15/2020

3732

Germany will take a stake in CureVac, a biotechnology company that is working to develop a COVID-19 vaccine, Minister of Economy, Peter Altmaier said on Monday. The Berlin government...

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Johnson & Johnson Prepares to Commence Human Trials for Its COVID-19 Vaccine

Rebecca Urena06/10/2020

4440

Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it will be commencing early-stage human trials for its budding coronavirus vaccine set to start in late July, sooner than the...

Biotechnology Investing News Market News

Eli Lilly and Company Provides Update Experimental COVID-19 Drug

financial buzz06/01/2020

5137

Eli Lilly and Company (NYSE: LLY) announced on Monday that patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19. According...

Biotechnology Investing News Market News Technology

Akers Biosciences and Premas Biotech Reports Successful Expression of Three Coronavirus Antigens

Danny Abramov04/08/2020

2729

Akers Biosciences, Inc. (NASDAQ: AKER) announced Wednesday that its collaboration with Premas Biotech has successfully completed a second milestone, the effective expression of the three coronavirus antigens, Spike (S),...

Biotechnology Investing News Market News Technology

Novavax Shares Rise After Coronavirus Vaccine Candidate was Identified and Initiation of Trial Accelerated

Danny Abramov04/08/2020

3589

Novavax, Inc. (NASDAQ: NVAX) shares surged more than 20% Wednesday after the Company announced that it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using...

Tag: Vaccine

Johnson & Johnson to Deliver U.S 100 Million Doses of Coronavirus Vaccine

BioNTech SE and Pfizer Inc. announced initial data from their ongoing German Phase ½ COVID-19 Vaccine Study

J&J Profit Plummets 35%

Biotech Sector Pursues a Vaccine as COVID-19 Cases Continue to Rise

Catalent and Moderna Report Collaboration to Manufacture Moderna’s Coronavirus Vaccine Candidate

Germany to Acquire stake in CureVac to Search for Coronavirus Vaccine

Johnson & Johnson Prepares to Commence Human Trials for Its COVID-19 Vaccine

Eli Lilly and Company Provides Update Experimental COVID-19 Drug

Akers Biosciences and Premas Biotech Reports Successful Expression of Three Coronavirus Antigens

Novavax Shares Rise After Coronavirus Vaccine Candidate was Identified and Initiation of Trial Accelerated

About Us

Instagram

Latest Tweets